Literature DB >> 24461453

Staphylococcus aureus: the multi headed hydra resists and controls human complement response in multiple ways.

Peter F Zipfel1, Christine Skerka2.   

Abstract

The Gram positive human pathogen Staphylococcus aureus causes a spectrum of human diseases including pneumonia, tissue and skin infections, endocarditis, pneumonia and sepsis. The increasing number of resistant bacteria and the threat of methicillin resistant S. aureus (MRSA) urge for the need to develop new antibacterial compounds. A prerequisite for development of such anti microbial compounds is a better understanding of the complex immune crosstalk between the pathogenic bacterium and its human host. To this end proteins staphylococcal proteins that contribute to innate immune evasion especially to complement control need to be identified and their mode of action needs to be analyzed in order to provide new targets for immune interference.
Copyright © 2014. Published by Elsevier GmbH.

Entities:  

Keywords:  Complement; Immune escape pathogenic bacteria

Mesh:

Substances:

Year:  2013        PMID: 24461453     DOI: 10.1016/j.ijmm.2013.11.004

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  11 in total

1.  Proteomic Identification of saeRS-Dependent Targets Critical for Protective Humoral Immunity against Staphylococcus aureus Skin Infection.

Authors:  Fan Zhao; Brian L Cheng; Susan Boyle-Vavra; Maria-Luisa Alegre; Robert S Daum; Anita S Chong; Christopher P Montgomery
Journal:  Infect Immun       Date:  2015-07-13       Impact factor: 3.441

Review 2.  Staphylococcus aureus Aggregation and Coagulation Mechanisms, and Their Function in Host-Pathogen Interactions.

Authors:  H A Crosby; J Kwiecinski; A R Horswill
Journal:  Adv Appl Microbiol       Date:  2016-08-04       Impact factor: 5.086

3.  Staphylococcus aureus modulation of innate immune responses through Toll-like (TLR), (NOD)-like (NLR) and C-type lectin (CLR) receptors.

Authors:  Fatemeh Askarian; Theresa Wagner; Mona Johannessen; Victor Nizet
Journal:  FEMS Microbiol Rev       Date:  2018-09-01       Impact factor: 16.408

4.  Nanobioarchitectures based on chlorophyll photopigment, artificial lipid bilayers and carbon nanotubes.

Authors:  Marcela Elisabeta Barbinta-Patrascu; Stefan Marian Iordache; Ana Maria Iordache; Nicoleta Badea; Camelia Ungureanu
Journal:  Beilstein J Nanotechnol       Date:  2014-12-02       Impact factor: 3.649

Review 5.  Novel Evasion Mechanisms of the Classical Complement Pathway.

Authors:  Brandon L Garcia; Seline A Zwarthoff; Suzan H M Rooijakkers; Brian V Geisbrecht
Journal:  J Immunol       Date:  2016-09-15       Impact factor: 5.422

6.  Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack.

Authors:  Teresia Hallström; Melanie Uhde; Birendra Singh; Christine Skerka; Kristian Riesbeck; Peter F Zipfel
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

Review 7.  Antimicrobial Mechanisms of Macrophages and the Immune Evasion Strategies of Staphylococcus aureus.

Authors:  Ronald S Flannagan; Bryan Heit; David E Heinrichs
Journal:  Pathogens       Date:  2015-11-27

8.  Complement Effectors of Inflammation in Cystic Fibrosis Lung Fluid Correlate with Clinical Measures of Disease.

Authors:  Laura A Sass; Pamela S Hair; Amy M Perkins; Tushar A Shah; Neel K Krishna; Kenji M Cunnion
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

9.  The Plasmodium falciparum blood stages acquire factor H family proteins to evade destruction by human complement.

Authors:  Thiago F A Rosa; Ansgar Flammersfeld; Che J Ngwa; Meike Kiesow; Rainer Fischer; Peter F Zipfel; Christine Skerka; Gabriele Pradel
Journal:  Cell Microbiol       Date:  2015-11-12       Impact factor: 3.715

10.  Enolase From Aspergillus fumigatus Is a Moonlighting Protein That Binds the Human Plasma Complement Proteins Factor H, FHL-1, C4BP, and Plasminogen.

Authors:  Prasad Dasari; Naile Koleci; Iordana A Shopova; Dirk Wartenberg; Niklas Beyersdorf; Stefanie Dietrich; Alfredo Sahagún-Ruiz; Marc Thilo Figge; Christine Skerka; Axel A Brakhage; Peter F Zipfel
Journal:  Front Immunol       Date:  2019-11-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.